KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Zoetis (ZTS) EBITDA Margin (2016 - 2025)

Zoetis (ZTS) has disclosed EBITDA Margin for 13 consecutive years, with 41.54% as the latest value for Q2 2025.

  • On a quarterly basis, EBITDA Margin rose 5019.0% to 41.54% in Q2 2025 year-over-year; TTM through Jun 2025 was 28.95%, a 5650.0% decrease, with the full-year FY2024 number at 3.72%, down 4084.0% from a year prior.
  • EBITDA Margin was 41.54% for Q2 2025 at Zoetis, up from 31.59% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 349.12% in Q3 2024 to a low of 1603.45% in Q2 2023.
  • A 5-year average of 234.7% and a median of 30.03% in 2021 define the central range for EBITDA Margin.
  • Biggest YoY gain for EBITDA Margin was 159481bps in 2024; the steepest drop was -142048bps in 2024.
  • Zoetis' EBITDA Margin stood at 28.47% in 2021, then crashed by -106bps to 1.62% in 2022, then plummeted by -99022bps to 1603.45% in 2023, then surged by 102bps to 31.59% in 2024, then skyrocketed by 32bps to 41.54% in 2025.
  • Per Business Quant, the three most recent readings for ZTS's EBITDA Margin are 41.54% (Q2 2025), 31.59% (Q4 2024), and 349.12% (Q3 2024).